Skip to content
Free shipping over $200FedEx 2-day shipping
Routine Peptides
HPLC tested
Representative HPLCPer lot
BPC-157 / TB-500 research vial

Regenerative & Repair

BPC-157 / TB-500

Combined Tissue Repair Studies

Third-party testedCOA per lotView COA · 98.75%
$13820mg · $6.90/mg

Quantity

1

Ships from the United States with tracking · free shipping over $200

PassedSterility & Endotoxins
PassedNet Content & Purity
Research use only
Third-party tested
COA with every lot
Tracked shipping

Researchers also added

KLOW Blend

80mg

$168.00

TB-500

10mg

$102.00

Thymosin Alpha-1

10mg

$102.00

Authenticity

Every vial carries a code

Scan the code on the label to pull up every published certificate for that compound — the same reports the third-party laboratory issued, batch by batch. Traceable from the laboratory that tested it to your bench.

Verify a batch →

Verified, lot by lot

Per lot
  • Independently tested

    Purity is quantified by reverse-phase HPLC and identity confirmed by mass spectrometry, by an outside laboratory rather than in-house.

  • A certificate for your lot

    The report that ships with your order describes the batch you received — not the product line, and not a representative sample.

  • COA-backed replacement

    If material does not match the certificate issued for its lot, we replace it or refund it. Send us the lot number and we will trace it.

  • Tracked dispatch

    Tracking is issued when the label is created, so the shipment is traceable from the moment it leaves us.

🔄
2
Synergistic Pathways
VEGF + Actin regulation
📈
370+
Combined Studies
BPC-157 (200+) + TB-500 (170+)
61%
Faster Healing
TB-500 re-epithelialization
🎯
4
Research Areas
Tendon & Ligament · Wound Healing · Vascular Repair & more

About this compound

What BPC-157 / TB-500 is

Molecular model

A combination vial pairing BPC-157 with TB-500 at 20 mg total. The two appear together in repair research because their described routes differ: BPC-157 is associated with angiogenic and growth-factor signaling, while TB-500 acts on actin dynamics and cell migration. Studies of the individual components are far more numerous than studies of the pair.

Form
Lyophilized powder blend
Purity
Quantified by HPLC, reported per lot
Vial size
20mg
Class
Peptide blend
Read the full BPC-157 / TB-500 research monograph →

Full specification

Physical form
Lyophilized powder blend
Documented purity
Quantified by HPLC, reported per lot
Storage
-20°C for long-term stability
Solubility
Water-soluble

How it works

How BPC-157 / TB-500 works

The pathways BPC-157 / TB-500 acts on, and what each one does. Signalling described from preclinical models.

Angiogenesis & Cytoprotection

BPC-157

The BPC-157 component contributes the vascular arm — raised VEGF expression and new vessel formation, restoring supply to the injured area.

  • VEGF-mediated vessel formation
  • Nitric oxide system modulated
  • Cytoprotection reported in gastric and soft tissue

Cell Migration & Actin Regulation

TB-500

The TB-500 component sequesters G-actin and enables the cytoskeletal remodeling a cell needs in order to move toward the site.

  • Actin dynamics drive cell migration
  • Integrin-linked kinase activated
  • Fibrotic remodeling reduced

Complementary Repair Cascade

Synergy

The pairing is studied on the logic that one component restores supply while the other mobilises the cells that use it. Worth noting: the published research addresses each compound separately, not the combination.

  • One component restores blood supply
  • The other mobilises repair cells
  • Anti-inflammatory effects reported for both

Uses & applications

What BPC-157 / TB-500 is researched for

The main areas under study, and the study-reported figures behind them.

Musculoskeletal

Tendon & Ligament

Both constituents appear separately in tendon and ligament literature; the combination itself has not been studied at that level.

Chang et al. 2014

Dermatology

Wound Healing

Closure rate is measured, with the two components contributing vascular supply and cell migration respectively.

Malinda et al. 2007

Cardiovascular

Vascular Repair

Vessel formation comes from the BPC-157 arm and underpins the rest — repair elsewhere depends on restored supply.

Sikiric et al. 2019

Anti-Inflammatory

Inflammation Control

Cytokine and macrophage endpoints are attributed mainly to the TB-500 component in the published work.

Sikiric et al. 2011

What the published work measures

The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.

  • BPC-157 Tendon Healing
  • TB-500 Cell Migration
  • BPC-157 GHR Expression
  • TB-500 Wound Closure

What is in the vial

Inside BPC-157 / TB-500

This product is a mixture, so it has no single structure. These are the compounds it is blended from, each shown on its own.

BPC-157

Drag to rotate

100 atoms

CON

100 atoms, 103 bonds, C62H98N16O22. Connectivity and stereochemistry from PubChem CID 9941957. The arrangement is one computed low-energy conformer, not a measured structure — a flexible peptide adopts many conformations in solution. Hydrogens omitted for legibility.

TB-500

Drag to rotate

62 atoms

CON

62 atoms, 61 bonds, C38H68N10O14. Connectivity and stereochemistry from PubChem CID 62707662. The arrangement is one computed low-energy conformer, not a measured structure — a flexible peptide adopts many conformations in solution. Hydrogens omitted for legibility.

Molecular model

Sequence length
blend
Physical form
Lyophilized powder blend
Documented purity
Quantified by HPLC, reported per lot

Third-party verified

Independently tested, lot by lot.

Every batch of BPC-157 / TB-500 is sent to an accredited independent laboratory before it ships. Here is what we screen for.

HPLC purity analysis

Quantifies purity and reports it on the lot certificate

Mass spectrometry

Verifies the exact molecular identity

Heavy metals screening

Lead, arsenic, cadmium & mercury

Endotoxins (LAL)

Bacterial endotoxin levels

Sterility testing

No microbial contamination

Net peptide content

Actual peptide mass per vial verified

FAQ

Common questions about BPC-157 / TB-500

What is BPC-157 / TB-500?

+

A combination vial pairing BPC-157 with TB-500 at 20 mg total. The two appear together in repair research because their described routes differ: BPC-157 is associated with angiogenic and growth-factor signaling, while TB-500 acts on actin dynamics and cell migration. Studies of the individual components are far more numerous than studies of the pair.

What is BPC-157 / TB-500 researched for?

+

Published research on BPC-157 / TB-500 concentrates on Tendon & Ligament, Wound Healing, Vascular Repair and Inflammation Control. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.

How does BPC-157 / TB-500 work?

+

The literature describes BPC-157 / TB-500 acting across Angiogenesis & Cytoprotection, Cell Migration & Actin Regulation and Complementary Repair Cascade, reported respectively as BPC-157, TB-500 and Synergy. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.

How should BPC-157 / TB-500 be stored and reconstituted?

+

Store the sealed vial at -20°C, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. BPC-157 / TB-500 is water-soluble; reconstitute by directing the diluent down the vial wall rather than onto the powder, then swirl to dissolve rather than shaking. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.

Is BPC-157 / TB-500 approved for human use?

+

No. BPC-157 / TB-500 is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.

Cited sources

Peer-reviewed literature

Independent published research indexed from PubMed and peer-reviewed journals — not Routine Peptides claims.

  1. [1]PubMedStable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract (opens in a new tab)2011 · Sikiric P et al.View source →
  2. [2]PubMedThymosin beta 4 activates integrin-linked kinase and promotes cardiac cell migration (opens in a new tab)2004 · Bock-Marquette I et al.View source →
  3. [3]PubMedBPC 157 and NO system (opens in a new tab)2019 · Sikiric P et al.View source →
  4. [4]PubMedThymosin beta-4 promotes dermal healing (opens in a new tab)2007 · Malinda KM et al.View source →

For research use only

Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.

Before you order

Quality Becomes RoutineMeasured. Verified. Documented.

Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.